Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedAdvisor Limited ( (AU:MDR) ) has issued an update.
MedAdvisor Limited has entered into a binding agreement to sell its ANZ business division and related intellectual property to Jonas Software AUS Pty Ltd for a headline price of $35 million, with potential additional earnings based on future performance. This strategic move will allow MedAdvisor to focus on its US operations, while the sale proceeds will be used to settle existing debts and potentially return capital to shareholders, pending post-completion adjustments.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited is a global company specializing in pharmacy-driven patient engagement solutions. The company focuses on providing software and services that enhance patient interactions with pharmacies, primarily operating in the Australian, New Zealand, and US markets.
Average Trading Volume: 791,698
Technical Sentiment Signal: Sell
Current Market Cap: A$50.61M
Find detailed analytics on MDR stock on TipRanks’ Stock Analysis page.